The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALCOBRA LTD | SHS | M2239P109 | 3,780 | 625,792 | SH | SOLE | 625,792 | 0 | 0 | ||
| ALLERGAN PLC | SHS | G0177J108 | 4,842 | 17,813 | SH | SOLE | 17,813 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 13,639 | 129,501 | SH | SOLE | 129,501 | 0 | 0 | ||
| YPF SOCIEDAD ANONIMA | SPON ADR CL D | 984245100 | 34,268 | 2,250,000 | SH | Call | SOLE | 2,250,000 | 0 | 0 | |
| CF INDS HLDGS INC | COM | 125269100 | 20,838 | 464,101 | SH | SOLE | 464,101 | 0 | 0 | ||
| DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 9,445 | 265,376 | SH | SOLE | 265,376 | 0 | 0 | ||
| ECO STIM ENERGY SOLUTIONS IN | COM | 27888D101 | 7,306 | 2,130,000 | SH | SOLE | 2,130,000 | 0 | 0 | ||
| ENDO INTL PLC | SHS | G30401106 | 3,647 | 52,634 | SH | SOLE | 52,634 | 0 | 0 | ||
| GW PHARMACEUTICALS PLC | ADS | 36197T103 | 19,253 | 210,715 | SH | SOLE | 210,715 | 0 | 0 | ||
| IMPAX LABORATORIES INC | COM | 45256B101 | 21,359 | 606,618 | SH | SOLE | 606,618 | 0 | 0 | ||
| MYLAN N V | SHS EURO | N59465109 | 3,177 | 78,905 | SH | SOLE | 78,905 | 0 | 0 | ||
| NMI HLDGS INC | CL A | 629209305 | 56,023 | 7,371,500 | SH | SOLE | 7,371,500 | 0 | 0 | ||
| PRONAI THERAPEUTICS INC | COM | 74346L101 | 8,664 | 422,200 | SH | SOLE | 422,200 | 0 | 0 | ||
| VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 10,414 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||